Reply to: “Ketorolac following mastectomy: Is there an increased risk of reoperation?” Correspondence


Authors: McCormick, P. J.; Assel, M.; Van Zee, K. J.; Vickers, A. J.; Nelson, J. A.; Morrow, M.; Tokita, H. K.; Simon, B. A.; Twersky, R. S.
Title: Reply to: “Ketorolac following mastectomy: Is there an increased risk of reoperation?”
Keywords: hypertension; recurrence risk; letter; breast cancer; mastectomy; practice guideline; risk assessment; nonsteroid antiinflammatory agent; reoperation; hematoma; ketorolac; breast surgery; antithrombocytic agent; anticoagulant agent; recovery room; human
Journal Title: Annals of Surgical Oncology
Volume: 28
Issue: Suppl. 3
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2021-12-01
Start Page: S777
End Page: S778
Language: English
DOI: 10.1245/s10434-021-10073-3
PUBMED: 33961172
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Export Date: 3 January 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    777 Morrow
  2. Kimberly J Van Zee
    293 Van Zee
  3. Andrew J Vickers
    891 Vickers
  4. Melissa Jean Assel
    113 Assel
  5. Jonas Allan Nelson
    226 Nelson
  6. Rebecca Shoshana Twersky
    26 Twersky
  7. Hanae Tokita
    28 Tokita
  8. Brett Andrew Simon
    50 Simon